BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2218670)

  • 1. Prevalence of HIV infection among intravenous drug users: a view from New Orleans.
    Pena JM; Massochette J; Thompson KE
    South Med J; 1990 Oct; 83(10):1233. PubMed ID: 2218670
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
    Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV seroconversion studies among intravenous drug users.
    Vlahov D
    AIDS; 1994 Feb; 8(2):263-5. PubMed ID: 8043233
    [No Abstract]   [Full Text] [Related]  

  • 4. [AIDS and HIV infection in intravenous drug addicts in the Federal Republic of Germany].
    Stark K; Kleiber D
    Dtsch Med Wochenschr; 1991 May; 116(22):863-9. PubMed ID: 2036946
    [No Abstract]   [Full Text] [Related]  

  • 5. Components of difference in HIV seropositivity rate among injection drug users between low- and high-HIV-prevalence regions.
    Wang J
    AIDS Behav; 2003 Mar; 7(1):1-8. PubMed ID: 14534385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: "A method for estimating HIV transmission rates among female sex partners of male intravenous drug users".
    Allard R
    Am J Epidemiol; 1992 Mar; 135(5):589-90. PubMed ID: 1570827
    [No Abstract]   [Full Text] [Related]  

  • 7. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
    Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV risk behaviors and HIV seropositivity among young injection drug users.
    Marrero Rodríguez CA; Robles RR; Colón HM; Freeman DH; Matos TD; Reyes JC
    P R Health Sci J; 1993 Apr; 12(1):7-12. PubMed ID: 8511250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology in male and female intravenous drug users with and without HIV infection.
    Lipsitz JD; Williams JB; Rabkin JG; Remien RH; Bradbury M; el Sadr W; Goetz R; Sorrell S; Gorman JM
    Am J Psychiatry; 1994 Nov; 151(11):1662-8. PubMed ID: 7943458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incarceration history as a risk factor for HIV infection among Puerto Rican injection drug users.
    Robles RR; Marrero CA; Freeman DH; Colón HM; Matos TD; Sahai H
    P R Health Sci J; 1993 Apr; 12(1):13-7. PubMed ID: 8511241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathology in women with HIV disease and drug abuse.
    Pergami A; Gala C
    Am J Psychiatry; 1996 Mar; 153(3):448-9. PubMed ID: 8610851
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV infection among drug abusers in the Belgrade area.
    Kilibarda M
    Bull Narc; 1993; 45(1):135-46. PubMed ID: 8305903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV in the epicenter of the epicenter: HIV and drug use among criminal justice populations in New York City, 1980-2007.
    Freudenberg N
    Subst Use Misuse; 2011; 46(2-3):159-70. PubMed ID: 21303236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The survey of HIV prevalence among drug users in Guangxi, China].
    Zhang G; Zheng X; Liu W; Liang F; Qu S; Mao Y; Wang L; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):15-6. PubMed ID: 11860749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent lack of human immunodeficiency virus infection in intravenous drug users at very high risk.
    Boiocchi M; Franceschi S; Serraino D; Guarneri S; Tavian M; Diodato S
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):633-5. PubMed ID: 8496794
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989.
    Robert CF; Déglon JJ; Wintsch J; Martin JL; Perrin L; Bourquin M; Gabriel V; Hirschel B
    AIDS; 1990 Jul; 4(7):657-60. PubMed ID: 2397058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
    Des Jarlais DC; Arasteh K; Friedman SR
    Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.